Asimov
Asimov is seeking a Senior Associate Scientist to join the Synthetic Biology team for a 6-month contract role focused on developing stable producer cell lines for AAV and lentiviral vector therapeutics. The candidate will lead cell line development processes including transfection, cloning, and characterization while collaborating with process development teams to improve workflows. This position offers the opportunity to contribute to next-generation therapeutic manufacturing in a forward-thinking biotechnology startup.
Headquarters
Boston, Massachusetts, United States
Company Size
11-50 employees
Founded
2017
Asimov builds tools to program living cells. We're integrating mammalian synthetic biology with computer-aided design to advance therapeutic applications.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Asimov.
Asimov didn’t post a salary, so this is our estimate from similar listings.
Senior Scientist Vector Engineering
AstraZeneca
Senior Scientist Vector Engineering
AstraZeneca
Senior Scientist Vector Engineering
AstraZeneca
Senior Scientist – Functional Genomics
Amgen
Sr Scientist – Vector Engineering
AstraZeneca
Sr. Scientist - Viral Vector Expression (Biotechnology Discovery Research)
Eli Lilly and Company